Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roni Tamari
Early Fluid Overload Is a Serious Toxicity Associated With an Increased Risk of Non-Relapse Mortality After Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Disease Progression Is Main Barrier to Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Feasibility of Low Dose Azacitidine Post T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants in Patients With Myeloid Malignancies at High Risk for Relapse
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Ex Vivo CD34+–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease and High Treatment Response
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Empiric Anti-Thymocyte Globulin (ATG) Dosing in Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (Allo-Hct) May Result in ATG Overexposure That Negatively Affects Outcomes
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Double-Unit Cord Blood (CB) Transplantation (dCBT) Supplemented With Haplo-Identical CD34+ Cells May Be Associated With Enhanced Neutrophil Recovery but Successful Myeloid Bridging Is Strongly Influenced by Haplo CD34+ Cell Dose and Haplo-Winning CB Unit HLA-Match
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes Between CD34 + Selected or Unmodified Hematopoietic Stem Cells Transplants
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Impact of Pre-Transplant Measurable Residual Disease on Relapse Incidence and Progression-Free Survival in Older AML/MDS Patients Following Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
